Presence of Seropositive Patients to Trypanosoma cruzi in a Municipality of the Mixtec Sierra of the State of Puebla: A Preliminary Study

Abstract

Purpose

The state of Puebla has the social marginalization and ecological conditions for the transmission of infectious agents to be effective. Until a few years ago, the state of Puebla was considered non-endemic to the presence of Trypanosoma cruzi as there are no official reports of chronic cases. The objective of this work was to carry out a preliminary study on the prevalence of anti-T. cruzi antibodies in rural areas of the Huatlatlauca municipality in the Mixtec sierra of the state of Puebla.

Methods

A total of 196 serum samples from 12 rural localities were tested by using four tests: two enzyme-linked immunosorbent assays, an xenodiagnoses and PCR assay.

Results

Overall, 28 (14.2%) of 196 samples were positive for T. cruzi by ≥ 2 tests (95% CI 6.6–20.8%). Our results suggested that the municipality of Huatlatlauca in the Mixteca Sierra of the state of Puebla is an area with endemic potential for the disease with a high prevalence rate in the adult population and with cases in newborns, these high transmission rates are probably associated with problems of congenital and vector transmission.

Conclusion

Additional studies should be conducted to generate adequate campaigns for the control of Chagas disease in this area.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Alvarenga NJ, Brofen E (1997) Metaciclogênese do Trypanosoma cruzi como parâmetro de interação do parasita com o triatomíneo vetor. Rev Soc Bras Med Trop 30:247–250

    CAS  Article  Google Scholar 

  2. 2.

    Barbu C, Dumonteil E, Gourbière S (2010) Characterization of the dispersal of non-domiciliated Triatoma dimidiata through the selection of spatially explicit models. PLOS Negl Trop Dis 4(8):e777. https://doi.org/10.1371/journal.pntd.0000777

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Becerril M, Angeles-Pérez A, Noguez-García J, lmbert-Palafox J (2010) Riesgo de transmisión de trypanosoma cruzi en el municipio de Metztitlán, estado de Hidalgo, México, mediante la caracterización de unidades domiciliares y sus índices entomológicos. Neotrop Entomol 39(5):810–817

    Article  Google Scholar 

  4. 4.

    Briceño-León R (2009) La enfermedad de Chagas en las Américas: una perspectiva de ecosalud. Cadernos de Saúde Pública 25(Suppl 2):S71–S82

    Article  Google Scholar 

  5. 5.

    Carabarin-Lima A, González-Vázquez MC, Rodríguez-Morales O, Baylón-Pacheco L, Rosales-Encina JL, Reyes-López PA et al (2013) Chagas disease (American trypanosomiasis) in Mexico: an update. Acta Trop 127(2):126–135. https://doi.org/10.1016/j.actatropica.2013.04.007

    Article  PubMed  Google Scholar 

  6. 6.

    Costa de Albuquerque MA, Dias DM, Vieira LT, Lima CA, da Silva AM (2017) Mortality trends for neglected tropical diseases in the state of Sergipe, Brazil, 1980–2013. Infect Dis Poverty 6(1):20. https://doi.org/10.1186/s40249-016-0232-8

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Cruz-Reyes A, Pickering-Lopez JM (2006) Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years—a review. Memórias do Instituto Oswaldo Cruz 101:345–354

    Article  Google Scholar 

  8. 8.

    Dumonteil E, Gourbie`re S, Barrera-Perez M, Rodriguez-Felix E, Ruiz-Piña H, Baños-Lopez O et al (2002) Geographic distribution of Triatoma dimidiata and transmission dynamics of Trypanosoma cruzi in the Yucatan peninsula of Mexico. Am J Trop Med Hyg 67:176–183

    Article  Google Scholar 

  9. 9.

    Eisenstein M (2016) Disease: poverty and pathogens. Nature 531(7594):S61–S63. https://doi.org/10.1038/531S61a

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    García-Jordán N, Berrizbeitia M, Rodríguez J, Concepción JL, Cáceres A, Quiñones W (2017) Seroprevalence of Trypanosoma cruzi infection in the rural population of Sucre state, Venezuela. Cadernos de Saúde Pública. 33(10):e00050216

    Article  Google Scholar 

  11. 11.

    Guzmán-Gómez D, López-Monteon A, Lagunes-Castro MS, Álvarez-Martínez C, Hernández-Lutzon MJ, Dumonteil E et al (2015) Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic. Parasit Vectors 17(8):466. https://doi.org/10.1186/s13071-015-1072-2

    CAS  Article  Google Scholar 

  12. 12.

    Manne JM, Snively CS, Ramsey JM, Salgado MO, Barnighausen T, Reich MR (2013) Barriers to treatment access for Chagas disease in Mexico. PLOS Negl Trop Dis 7:e2488. https://doi.org/10.1371/journal.pntd.0002488

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Mischler P, Kearney M, McCarroll JC, Scholte RG, Vounatsou P, Malone JB (2012) Environmental and socio-economic risk modelling for Chagas disease in Bolivia. Geospatial Health 6(3):S59–S66

    Article  Google Scholar 

  14. 14.

    Monteón VM, Reyes-López PA, Sosa-Palacio A, León-Tello G, Martínez-Murguía J, Sosa-Jurado F (2005) Heterogeneous distribution of the prevalence of anti-Trypanosoma cruzi antibodies among blood donors in the state of Puebla, Mexico. Salud Pública de Mexico 47(2):116–125

    Article  Google Scholar 

  15. 15.

    Newton-Sánchez OA, Espinoza-Gómez F, Melnikov V, Delgado-Enciso I, Rojas-Larios F, Dumonteil E et al (2017) Seroprevalence of Trypanosoma cruzi (TC) and risk factors in Colima, Mexico. Gaceta Medica de Mexico 153(2):179–184

    PubMed  Google Scholar 

  16. 16.

    Ramos-Ligonio A, López-Monteon A, Guzmán-Gómez D, Rosales-Encina JL, Limón-Flores Y, Dumonteil E (2010) Identification of a hyperendemic area for Trypanosoma cruzi infection in central Veracruz, Mexico. Am J Trop Med Hyg 83(1):164–170. https://doi.org/10.4269/ajtmh.2010.09-0677

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Ramos-Ligonio A, Ramirez-Sanchez ME, Gonzalez-Hernandez JC, Rosales-Encina JL, Lopez-Monteon A (2006) Prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre del IMSS, Orizaba, Veracruz, Mexico. Salud Publica Mex 48:13–21

    Article  Google Scholar 

  18. 18.

    Sánchez-Guillén MC, Barnabé C, Guégan JF, Tibayrenc M, Velásquez-Rojas M, Martínez-Munguía J et al (2002) High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the state of Puebla, a non-endemic area of Mexico. Memórias do Instituto Oswaldo Cruz 97(7):947–952

    Article  Google Scholar 

  19. 19.

    Sánchez-Guillén MC, López-Colombo A, Ordóñez-Toquero G, Gomez-Albino I, Ramos-Jimenez J, Torres-Rasgado E et al (2006) Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico. Memórias do Instituto Oswaldo Cruz. 101(7):733–740

    Article  Google Scholar 

  20. 20.

    Sandoval-Ruiz CA, Zumaquero-Rios JL, Rojas-Soto O (2008) Predicting geographic and ecological distributions of triatomine species in the southern Mexican state of Puebla using ecological niche modeling. J Med Entomol 45(3):540–546

    CAS  Article  Google Scholar 

  21. 21.

    Secretaría de Salud (2014b) Prevención y control de la enfermedad de Chagas: Programa sectorial de salud 2013–2018, México, recuperado. http://www.cenaprece.salud.gob.mx/descargas/pdf/PAE_PrevencionControlEnfermedadChagas2013_2018.pdf. Accessed 10 Sept 2018

  22. 22.

    Secretaría de Salud (2014c) Subsecretaría de Prevención y Promoción de la Salud. CENAPRECE. Manual de diagnóstico y tratamiento de la enfermedad de chagas. 2014, México recuperado. https://www.gob.mx/cms/uploads/attachment/file/235962/ManualDX_TxEnfermedadCHAGAS2015.pdf. Accessed 10 Sept 2018

  23. 23.

    SEDESOL (2017) Subsecretaría de prospectiva, planeación y evaluación, informe anual sobre la situación de pobreza y rezago social. Recuperado https://www.gob.mx/cms/uploads/attachment/file/38233/Puebla_070.pdf. Accessed 15 Oct 2018

  24. 24.

    Solís H, De Carvalho E, Ferreira C, Casanova C, Huamán A, Mendoza V (2003) Contribución al estudio de la epidemiología de la enfermedad de Chagas en tres localidades de la zona sur del Perú. Anales de la Facultad de Medicina 64(4):223–227

    Article  Google Scholar 

  25. 25.

    Souza RM, Amato Neto V (2012) Discrepancies and consequences of indirect hemagglutination, indirect immunofluorescence and ELISA tests for the diagnosis of Chagas disease. Revista do Instituto de Medicina Tropical de São Paulo 54(3):141–143

    Article  Google Scholar 

  26. 26.

    Tarleton RL, Gurtler RE, Urbina JA, Ramsey J, Viotti R (2014) Chagas disease and the London declaration on neglected tropical diseases. PLOS Negl Trop Dis 8(10):e3219. https://doi.org/10.1371/journal.pntd.0003219

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    WHO (2017) Chagas disease (American trypanosomiasis) descriptive note March 2017. http://www.who.int/mediacentre/factsheets/fs340/es/. Accessed 13 Aug 2018

Download references

Acknowledgements

The authors would like to thank the vice-rectory of research and post-grade studies of the Meritorious Autonomous University of Puebla.

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. Ramos-Ligonio.

Ethics declarations

Conflict of Interest

The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zumaquero-Ríos, L., Sarracent-Pérez, J., Sandoval-Ruiz, C. et al. Presence of Seropositive Patients to Trypanosoma cruzi in a Municipality of the Mixtec Sierra of the State of Puebla: A Preliminary Study. Acta Parasit. 65, 19–26 (2020). https://doi.org/10.2478/s11686-019-00118-9

Download citation

Keywords

  • Seroprevalence
  • Trypanosoma cruzi
  • Antibodies
  • Chagas disease
  • Puebla state